Ovid Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.

About OVID

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.

CEO

Jeremy Max Levin

CEOJeremy Max Levin

Employees

Employees23

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2014

Founded2014

Employees

Employees23

OVID Key Statistics

Market cap

73.25M

Market cap73.25M

Price-Earnings ratio

-1.92

Price-Earnings ratio-1.92

Dividend yield

—

Dividend yield—

Average volume

2.23M

Average volume2.23M

High today

$1.08

High today$1.08

Low today

$0.9389

Low today$0.9389

Open price

$0.96

Open price$0.96

Volume

1.20M

Volume1.20M

52 Week high

$1.47

52 Week high$1.47

52 Week low

$0.2425

52 Week low$0.2425

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own OVID. This list is generated using Robinhood data, and it’s not a recommendation.

Ovid Therapeutics

Why Robinhood?

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY. Show more

OVID Key Statistics

Analyst ratings

100%

People also own

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.